Dalazatide (SHK-186) is a peptide-based blocker of KV1.3 channel used for treating autoimmune diseases. It is a first-in-class and investigational drug that may be used for the treatment of autoimmune diseases such as lupus erythematosus, psoriasis, rheumatoid arthritis, inflammatory bowel disease, type 1 diabetes, and multiple sclerosis (MS).

纯度：≥98%

CAS：1081110-69-1